Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
申请人:Bristol-Myers Squibb Company
公开号:EP0476493A1
公开(公告)日:1992-03-25
This invention relates to structurally novel acyclic tocotrienol analogs, which are useful for cholesterol/lipid lowering in cases of hypercholesterolemia and hyperlipidemia, and for atherosclerosis. Also provided are pharmaceutical compositions and a method of use employing those compositions.
Acyclic Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
申请人:Bristol-Myers Squibb Company
公开号:EP0571928A1
公开(公告)日:1993-12-01
This invention relates to structurally novel acyclic tocotrienol analogs, which are useful for cholesterol/lipid lowering in cases of hypercholesterolemia and hyperlipidemia, and for atherosclerosis. Also provided are pharmaceutical compositions and a method of use employing those compositions.
[EN] PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS<br/>[FR] PROCEDE DE SYNTHESE DE D-TOCOTRIENOLS
申请人:YASOO HEALTH INC
公开号:WO2005035490A2
公开(公告)日:2005-04-21
A process of forming a d-tocotrienols from a (2S) 2-hydroxymethyl-6-hydroxy-alkylchroman compound, through reaction with a farnesy1 Grignard or sulfone compound. Various methods of making the (2S) 2-hydroxymethyl-6-hydroxy- alklychroman compound are disclosed.
Process for synthesizing d-tocotrienols
申请人:Couladouros A. Elias
公开号:US20050124687A1
公开(公告)日:2005-06-09
A process of forming a d-tocotrienols from a (2S) 2-hydroxymethyl-6-hydroxy-alkylchroman compound, through reaction with a farnesyl Grignard or sulfone compound. Various methods of making the (2S) 2-hydroxymethyl-6-hydroxy-alklychroman compound are disclosed.